Regression of an acral lentiginous melanoma with an immunotherapy using a Mycobacterium tuberculosis-extracted polysaccharide complex (Tubercin)

International Journal of Dermatology

Volumn 41, Issue 1, 2002, Pages 52-53

  Chung, Tai Ho ^a,b   Jun, Jae Bok ^a   Jang, Jae Won ^a   Chung, Hai Lee ^a  

^a Catholic University of Daegu   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; TUBERCIN; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; BONE SCINTISCANNING; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MELANOMA; METASTASIS; PATIENT REFERRAL; PHYSICAL EXAMINATION; SIDE EFFECT; SKIN BIOPSY; SUN EXPOSURE; THUMB;

ADJUVANTS, IMMUNOLOGIC; AGED; BACTERIAL PROTEINS; FEMALE; FINGERS; HUMANS; IMMUNOTHERAPY; MELANOMA; MYCOBACTERIUM TUBERCULOSIS; SKIN NEOPLASMS;

EID: 0036185275     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0011-9059.2001.01388.x     Document Type: Conference Paper

References (9)

1. Melanoma vaccines
2. BCG immunotherapy of malignant melanoma: Summary of a seven-year experience
3. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma
4. Quality of life adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group Study
5. Anti-tumor effect of a Tuberculo-protein complex, Tubercin-3, and its isoelectrofocusing analysis
6. Trial of immunotherapeutic approach with Tuberculo-protein carbohydrate complex, Tubercin-3 on 500 cases of various cancers in men
7. Effect of Tubercin-3 on two cases of malignant melanoma
8. Effect of Tubercin-3 to the delayed cutaneous hypersensitivity to 2,4-dinitrochloroben-zene (DNCB) in cancer patients
9. Tumors of the skin